Cite
Nishimura T, Nagata S, Uehara T, et al. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography. Ann Nucl Med. 1996;10(1):71-8doi: 10.1007/BF03165056.
Nishimura, T., Nagata, S., Uehara, T., Morozumi, T., Ishida, Y., Nakata, T., Iimura, O., Kurata, C., Wakabayashi, Y., Sugihara, H., Otsuki, K., Wada, T., & Koga, Y. (1996). Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography. Annals of nuclear medicine, 10(1), 71-8. https://doi.org/10.1007/BF03165056
Nishimura, T, et al. "Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography." Annals of nuclear medicine vol. 10,1 (1996): 71-8. doi: https://doi.org/10.1007/BF03165056
Nishimura T, Nagata S, Uehara T, Morozumi T, Ishida Y, Nakata T, Iimura O, Kurata C, Wakabayashi Y, Sugihara H, Otsuki K, Wada T, Koga Y. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography. Ann Nucl Med. 1996 Feb;10(1):71-8. doi: 10.1007/BF03165056. PMID: 8814730.
Copy
Download .nbib